期刊文献+

沙利度胺治疗多发性骨髓瘤的研究进展 被引量:1

原文传递
导出
摘要 目的:介绍沙利度胺治疗多发性骨髓瘤(MM)的临床新进展,并展望其应用前景。方法:从沙利度胺治疗MM的作用机制及临床研究两方面进行分析、探讨。结果:沙利度胺治疗MM有着多方面的作用机制,其对于复发难治及初治的MM均有一定的作用,且不良反应可以耐受。结论:沙利度胺在治疗MM方面取得了令人瞩目的效果,但如何合理使用沙利度胺治疗多发性骨髓瘤仍存在一些问题有待解决。
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2009年第18期1573-1575,共3页 Chinese Journal of Hospital Pharmacy
  • 相关文献

参考文献28

  • 1Singhal S, Mehta J, Desikan R, et al. Antitumour activity of thalidomide in refractory multiple myeloma [J ]. New England Journal of Medicine,1999,341 : 1565-1572. 被引量:1
  • 2Raimondo FD, Azzaro MP, Palumbo GA, et al. Angiogenic factord in multiple myeloma: higher levels in bone marrow than in peripheral blood [J]. Haematologica, 2000,85:800-805. 被引量:1
  • 3Sfiridaki A, Miyakis S, Tsirakis G,et al. Systemic levels of interleukin-6 and matrix metallop roteinase-9 in patients with multiple myeloma may be useful as prognostic indexes of bone disease [J]. Clin Chem Lab Med, 2005,43 (9): 934-938. 被引量:1
  • 4Gelati M,Corsini E, Frigerio S, et al. Effects of thalidomide on parameters involved in angiogenesis: an in vitro study[J]. J Neurooncol, 2003,64 (3) : 193-201. 被引量:1
  • 5Hideshima T, Chauhan D, Shima Y, et al. Thalidomide and its analogs overcome drug resistance of human multiple myeloma cells to conventional therapy[J]. Blood, 2000 , 96 : 2943-2950. 被引量:1
  • 6Gupta D, Treon SP, Shima Y, et al. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion : therapeutic applications [J].Leukemia,2001 ; 15 : 1950-1961. 被引量:1
  • 7Hideshima T, Chauhan D, Podar, et al. Novel therapies targeting the myeloma cell and its bone marrow microenvironment [J ]. Semin-Oncol,2001,28(6) :607- 612. 被引量:1
  • 8Peuckmann V, Fisch M,Bruera E,et al, Potential novel uses of thalidomide: focus on palliative care [J]. Drugs, 2000-60 (2) : 273-292. 被引量:1
  • 9Haslett PA, Corral LG, Albert M, et al. Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD + 8 subset [J]. J Exp Med, 1998,187(11 ) : 1885-1892. 被引量:1
  • 10Laura G, Patrick A, George W, et al. Differentral cytokine modulation and T cell acativation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-α[J]. The Journal of Immunology, 1999,163 : 380-386. 被引量:1

二级参考文献8

  • 1Kimata Y,Higashio H,Kohno K.Impaired proteasome function rescues thermosensitivity of yeast cells lacking the coatomer subunit epsilon-COP,J Biol Chem,2000,275:10655-10660. 被引量:1
  • 2Singhal S,Mehta ,J.Desikan R,et al.Antitumor activity of thalidomide in refractory multiple myeloma.N Engl J Med,1999,341:1565-1571. 被引量:1
  • 3Gupta D,Treon SP,Shina Y,et al.Adherence of multiple myeloma cells to bone narrow stromal cells upregulates vascular endothelial growth factor secretion:therapeutic application.Leukemia,2001,15:1950-1961. 被引量:1
  • 4Mandruzzato S,Brasseur F,Andry G,et al.A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neckcarcinoma,J Exp Med,1997,186:785-793. 被引量:1
  • 5Patton WF,Erdjument-Bromage H,Marks AR.et al.Components of the protein synthesis and folding machinery are induced in vascular smooth muscle cells by hypertrophic and hyperplastic agents.Identification by comparative protein phenotyping and microsequencing.J Biol Chem,1995,270:21404-21410. 被引量:1
  • 6Mathiasen IS,Sergeev IN,Bastholm L,et al.Calcium and calpain as key mediators of apoptosis-like death induced hy vitamin D compounds in breast cancer cells.J Biol Chem,2002,277:30738-30745. 被引量:1
  • 7朱红霞,刘爽,周翠琦,周晓波,张帆,全兰平,徐宁志.抗凋亡基因survivin促进细胞转化的作用机制[J].中华医学杂志,2002,82(5):338-340. 被引量:77
  • 8李峰敏,王玉荣,徐建民.反应停诱导骨髓瘤细胞株(KM3)凋亡的初步研究[J].中国临床医学,2002,9(1):9-11. 被引量:14

共引文献5

同被引文献11

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部